Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 711

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 711
---
 hereof. These authorities are subject to change and differing interpretations. Any such change, which could be retroactive, could alter the tax consequences to holders of Kineta Common Stock as described herein. No advance ruling is being sought or obtained from the IRS regarding the U.S. federal income tax consequences of the Mergers nor are the statements in this discussion binding on the IRS or a court. As a result, there can be no assurances that the tax considerations described in this discussion will not be challenged by the IRS or sustained by a court if so challenged. This discussion does not address all U.S. federal income tax consequences that may be relevant to the particular circumstances of a Kineta common stockholder. In addition, it does not address consequences relevant to holders of Kineta Common Stock that are subject to particular U.S. or non-U.S.tax rules, including, without limitation:

| • |     | persons who are not U.S. Holders as defined below; |

| • |     | persons who do not hold their Kineta Common Stock as a “capital asset” within the meaning of Section 1221 of the Code; |

| • |     | persons who hold their Kineta Common Stock in a functional currency other than the U.S. dollar; |

| • |     | persons who hold Kineta Common Stock that constitutes “qualified small business stock” under Section 1202 of the Code or as “Section 1244 stock” for purposes of Section 1244 of the Code; |

| • |     | persons holding Kineta Common Stock as part of an integrated investment (including a “straddle,” pledge against currency risk, “constructive” sale or “conversion” transaction or other integrated or risk reduction transactions) consisting of shares of Kineta Common Stock and one or more other positions; |

| • |     | banks, insurance companies, mutual funds, tax-exempt entities, financial institutions, broker-dealers, real estate investment trusts or regulated investment companies; |

| • |     | “S corporations” or entities classified as partnerships or disregarded entities for U.S. federal income tax purposes (and investors therein); |

| • |     | persons who acquired their Kineta Common Stock pursuant to the exercise of compensatory options or in other compensatory transactions; |

| • |     | persons who acquired their Kineta Common Stock pursuant to the exercise of warrants or conversion rights under convertible instruments; |

| • |     | persons required to accelerate the recognition of any item of gross income with respect to the